Periodical U.S. Reports: United States v. Glaxo Group Ltd., 410 U.S. 52 (1973).
About this Item
Title
- U.S. Reports: United States v. Glaxo Group Ltd., 410 U.S. 52 (1973).
Names
- White, Byron Raymond (Judge)
- Supreme Court of the United States (Author)
Created / Published
- 1972
Headings
- - Law
- - Patents
- - Health
- - Law Library
- - Supreme Court
- - United States
- - Government Documents
- - Judicial review and appeals
- - Intellectual property
- - Government
- - Injunctions
- - Manufacturing
- - Commerce
- - Competition and antitrust
- - Prescription drugs
- - U.S. Reports
- - Common law
- - Court opinions
- - Judicial decisions
- - Court cases
- - Court decisions
- - Sherman Act
- - Restraints of trade
- - Unpatentable
- - Unpatented
- - Patent validity
- - Griseofulvin
- - Sales restriction
- - Dosage form patent
- - Reasonable royalty licensing
- - Patent pooling
- - Cross licensing
- - Periodical
Genre
- Periodical
Notes
- - Description: U.S. Reports Volume 410; October Term, 1972; United States v. Glaxo Group Ltd. et al.
Call Number/Physical Location
- Call Number: KF101
- Series: Intellectual Property Law
- Series: Antitrust Law
- Series: Volume 410
Source Collection
- U.S. Reports
Online Format
IIIF Presentation Manifest
Part of
Subject
- Antitrust Law
- Commerce
- Common Law
- Competition and Antitrust
- Court Cases
- Court Decisions
- Court Opinions
- Cross Licensing
- Dosage Form Patent
- Government
- Government Documents
- Griseofulvin
- Health
- Injunctions
- Intellectual Property
- Intellectual Property Law
- Judicial Decisions
- Judicial Review and Appeals
- Law
- Law Library
- Manufacturing
- Patent Pooling
- Patent Validity
- Patents
- Periodical
- Prescription Drugs
- Reasonable Royalty Licensing
- Restraints of Trade
- Sales Restriction
- Sherman Act
- Supreme Court
- U.S. Reports
- United States
- Unpatentable
- Unpatented